Clinical Trial Update: Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Patients [Phase 2, Phase 3]

View source ↗

Summary

A pediatric study evaluating intravenous amisulpride for prevention of postoperative nausea and vomiting has completed Phase 2/Phase 3 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Amisulpride (amisulpride)

Snippet

Sponsor: Acacia Pharma Ltd | Conditions: Nausea and Vomiting, Postoperative | Phase 2, Phase 3 | Status: COMPLETED